Joincare Pharmaceutical Group Industry Co (SHSE:600380) Change In Receivables : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co Change In Receivables?

Joincare Pharmaceutical Group Industry Co's change in receivables for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Joincare Pharmaceutical Group Industry Co's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Joincare Pharmaceutical Group Industry Co's change in receivables for the fiscal year that ended in Dec. 2024 was ¥122 Mil. It means Joincare Pharmaceutical Group Industry Co's Accounts Receivable declined by ¥122 Mil from Dec. 2023 to Dec. 2024 .

Joincare Pharmaceutical Group Industry Co's Accounts Receivable for the quarter that ended in Mar. 2025 was ¥2,590 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Joincare Pharmaceutical Group Industry Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 57.80.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Joincare Pharmaceutical Group Industry Co's liquidation value for the three months ended in Mar. 2025 was ¥6,207 Mil.

Joincare Pharmaceutical Group Industry Co Change In Receivables Historical Data

The historical data trend for Joincare Pharmaceutical Group Industry Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joincare Pharmaceutical Group Industry Co Change In Receivables Chart

Joincare Pharmaceutical Group Industry Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-647.41

-1,593.69

2,380.94

6,974.01

122.42

Joincare Pharmaceutical Group Industry Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Joincare Pharmaceutical Group Industry Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Joincare Pharmaceutical Group Industry Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2590.449	/	4089.279	*	91
=	57.80

2. In Ben Graham's calculation of liquidation value, Joincare Pharmaceutical Group Industry Co's accounts receivable are only considered to be worth 75% of book value:

Joincare Pharmaceutical Group Industry Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	14936.402	-	11914.949	+	0.75 * 2590.449	+	0.5 * 2484.79
=	6,207

Joincare Pharmaceutical Group Industry Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Joincare Pharmaceutical Group Industry Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No. 17, Langshan Road, North District, High-tech Zone, Nanshan District, Guangdong, Shenzhen, CHN, 518057

Website

http://www.joincare.com

Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.

Executives

Xie You Guo	Supervisors
Yu Xiong	Directors, senior managers
Zhao Feng Guang	senior management
Qiu Qing Feng	Directors, senior managers
Tang Ling Zhi	senior management
Lin Nan Qi	Directors, senior managers
Cao Ping Wei	Director
Feng Yan Fang	Director
Zhong Shan	senior management
Yang Dong Yun	senior management
Peng Jin Hua	Supervisors
Guo Xiao Yun	Supervisors
Su Qing Wen	senior management

Joincare Pharmaceutical Group Industry Co Headlines

No Headlines